The immunosuppressant Rituximab may ease arthritis — an inflammation of the joints — in patients with long-standing systemic sclerosis (SSc), a small Turkish study found.
Moreover, in some patients, skin and lung symptoms either remained stable or eased, the researchers also observed. Read more here.
Comments are closed.
Scleroderma Queensland Support Group